Millions of people worldwide are affected by Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Yet the causes, diagnostic markers, progression, and FDA-approved treatments remain unknown. The shared vision of the ME/CFS Collaborative Research Network (ME/CFSnet) is to encourage collaborative research in partnership with individuals and advocacy groups to understand the disease and develop better diagnosis and treatment.
Invest in ME Research International Conference Week | May 26-30, 2025
May 26, 2025
Save the date! The international ME conference week events are planned for May 26-30, 2025. More details will be forthcoming over the next months.
Take Me ThereNIH ME/CFS Advocacy Call | January 2025
January 14, 2025
NIH's next ME/CFS Webinar will be held on January 14, 2025 from 2:00 – 3:00 pm ET. The webinar will include updates from NIH on ME/CFS-related research activities and a presentation by Vikram Chib, PhD, and Agostina Casamento-Moran, PhD, from Johns Hopkins University. Click below to register.
Take Me ThereNew Publication! New Research Finds T Cell Exhaustion in ME/CFS
December 2, 2024
New research from MECFSnet investigators finds T cell exhaustion as a hallmark of ME/CFS using multiomic analysis. These findings may provide the basis for future therapeutic approaches. This study was published in PNAS.
Take Me ThereThese institutions are working together as the ME/CFS Research Network.
Visit the CDC to learn more about ME/CFS.
Investigators, health care providers, and advocates are collaborating across the Research Network to drive progress in understanding ME/CFS. Together, we can advance discoveries to improve the lives of members of the ME/CFS community.
What is ME/CFS?
Myalgic Encephalomyelitis (ME), also referred to as Chronic Fatigue Syndrome (CFS), is a multi-system disease that causes dysfunction of the neurological, immune, endocrine, and energy metabolism systems.